This FDA InspectorProfile is a report of relevant audit-related information on Anna Lazar, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.
This InspectorProfile report is updated through and lists Anna Lazar's inspections in 12 countries: Germany, Hungary, Finland, Canada, France, Italy, Switzerland, Sweden, Czech Republic, Japan, United Kingdom, and United States.
FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Anna Lazar's inspection information so that you can mitigate investigator-related risks.
Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Anna Lazar.
Note: The EIR and 483 documents are sold separately.